AR-226-3580 - Definitive Study: Quantitative Screening of Commercial Lots of Human Serum Obtained in 2004 for Endogenous Fluorochemicals Using Solid Phase Extraction and Liquid Chromatography/Tandem Mass Spectrometry

1 recorded connections shown. Select a record, office or person to follow its source references.

Start with

and connect to

Zoom to read. Drag to explore. Select a connection.

Rulemaking document · As of Aug 14, 2026

AR-226-3580 - Definitive Study: Quantitative Screening of Commercial Lots of Human Serum Obtained in 2004 for Endogenous Fluorochemicals Using Solid Phase Extraction and Liquid Chromatography/Tandem Mass Spectrometry: 1 outgoing connections shown. Point at anyone to see how they are linked.Showing bounded source connections. Dates come from the held records; missing relationships remain unknown.

The source record

As of Aug 14, 2026.

Document type: Supporting & Related Material
Subtype: Report
Title: AR-226-3580 - Definitive Study: Quantitative Screening of Commercial Lots of Human Serum Obtained in 2004 for Endogenous Fluorochemicals Using Solid Phase Extraction and Liquid Chromatography/Tandem Mass Spectrometry
Posted date: 2026-07-22T04:00:00+00:00
Last modified date: 2026-07-23T00:32:26+00:00
Within comment period: false
Open for comment: false
Withdrawn: false
Ingested at: 2026-08-14T07:01:04.460654+00:00

Every link on this map

The same connections as a table, with the reason each one is here.

Sort by

Connections of AR-226-3580 - Definitive Study: Quantitative Screening of Commercial Lots of Human Serum Obtained in 2004 for Endogenous Fluorochemicals Using Solid Phase Extraction and Liquid Chromatography/Tandem Mass Spectrometry

Rulemaking document	What this connects to	AR-226-3580 - Definitive Study: Quantitative Screening of Commercial Lots of Human Serum Obtained in 2004 for Endogenous Fluorochemicals Using Solid Phase Extraction and Liquid Chromatography/Tandem Mass Spectrometry has a recorded connection to Rulemaking document.	None